Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Eight Lin

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Pharmacology|March 17, 2023
Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndromeShun-Chin Yang, Yi-Hsuan Wang, Chiu-Ming Ho, et al.
RSC Advances|November 1, 2023
Synthesis and evaluation of potent (iso)ellipticine-based inhibitors of MYLK4 accessed <i>via</i> expeditious synthesis from isoquinolin-5-olSzu Lee, Min-Wu Chao, Yi-Wen Wu, et al.
European Journal of Medicinal Chemistry|February 15, 2021
CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibitionArshdeep Singh, Ting-Yu Chang, Navdeep Kaur, et al.
Journal of Food and Drug Analysis|June 19, 2023
Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activityHuang-Ju Tu, Chih-Jou Su, Chao-Shiang Peng, et al.
Protein Science : a Publication of the Protein Society|May 9, 2024
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancerCheng-Chiao Huang, Chia-Ming Hsu, Min-Wu Chao, et al.
Scientific Reports|June 14, 2017
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening ApproachKai-Cheng Hsu, Chang-Yi Liu, Tony Eight Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 25, 2021
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatmentTony Eight Lin, Chia-Ron Yang, Ching-Hsuan Chou, et al.
Biochemical Pharmacology|September 23, 2025
Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndromeChun-Yu Chen, Yu-Ting Kuo, Chih-Chuang Liaw, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2023
The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivoTai-Yuan Ho, Ting-Yi Sung, Shiow-Lin Pan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 24, 2024
Synthesis and biological evaluation of <i>ortho</i>-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylasesKai-Cheng Hsu, Yun-Yi Huang, Jung-Chun Chu, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Pharmacology|March 17, 2023
Targeting formyl peptide receptor 1 with anteiso-C13-surfactin for neutrophil-dominant acute respiratory distress syndromeShun-Chin Yang, Yi-Hsuan Wang, Chiu-Ming Ho, et al.
RSC Advances|November 1, 2023
Synthesis and evaluation of potent (iso)ellipticine-based inhibitors of MYLK4 accessed <i>via</i> expeditious synthesis from isoquinolin-5-olSzu Lee, Min-Wu Chao, Yi-Wen Wu, et al.
European Journal of Medicinal Chemistry|February 15, 2021
CAP rigidification of MS-275 and chidamide leads to enhanced antiproliferative effects mediated through HDAC1, 2 and tubulin polymerization inhibitionArshdeep Singh, Ting-Yu Chang, Navdeep Kaur, et al.
Journal of Food and Drug Analysis|June 19, 2023
Urolithin A exhibits a neuroprotective effect against Alzheimer's disease by inhibiting DYRK1A activityHuang-Ju Tu, Chih-Jou Su, Chao-Shiang Peng, et al.
Protein Science : a Publication of the Protein Society|May 9, 2024
In silico identification of a novel Cdc2-like kinase 2 (CLK2) inhibitor in triple negative breast cancerCheng-Chiao Huang, Chia-Ming Hsu, Min-Wu Chao, et al.
Scientific Reports|June 14, 2017
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening ApproachKai-Cheng Hsu, Chang-Yi Liu, Tony Eight Lin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 25, 2021
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatmentTony Eight Lin, Chia-Ron Yang, Ching-Hsuan Chou, et al.
Biochemical Pharmacology|September 23, 2025
Butyrolactone I from Aspergillus fungi blocks neutrophil FPR1 to alleviate acute respiratory distress syndromeChun-Yu Chen, Yu-Ting Kuo, Chih-Chuang Liaw, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 10, 2023
The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivoTai-Yuan Ho, Ting-Yi Sung, Shiow-Lin Pan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 24, 2024
Synthesis and biological evaluation of <i>ortho</i>-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylasesKai-Cheng Hsu, Yun-Yi Huang, Jung-Chun Chu, et al.
Pageof 7